Growing Demand For Biologics On Mammalian Cell Fermentation Technology Market: Strategic Insights Driving Mammalian Cell Fermentation Technology Market Momentum in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Mammalian Cell Fermentation Technology Market Size By 2025?
The market for mammalian cell fermentation technology has experienced swift expansion in the past few years. Its projected growth is from $51.29 billion in 2024 up to $57.48 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 12.1%. The prior growth can be traced back to a surge in demand for biologics and biosimilars, further concentration on personalized medication, an amplified production of biopharmaceuticals, and heightened requirements for scalable and efficient cell culture techniques.

How Big Is the Mammalian Cell Fermentation Technology Market Size Expected to Grow by 2029?
The market value of mammalian cell fermentation technology is projected for substantial expansion in the coming years, expected to reach $89.54 billion in 2029, with an impressive compound annual growth rate (CAGR) of 11.7%. This growth during the projected period can be attributed to factors such as an increase in chronic disease prevalence, escalated investments from multinational corporations, a rising rate of chronic illnesses, the growing implementation of sophisticated bioprocessing strategies, escalating funds allocated for research and development of innovative recombinant proteins, and increasing demand for cancer treatments. Noteworthy trends to watch during this forecasted timeframe include advancements in cell culture technology, progress in bioreactor design, the development of next-generation bioprocessing technologies, the integration of varied multi-omics methodologies, and the acceleration of technology-led automation.

View the full report here:
https://www.thebusinessresearchcompany.com/report/mammalian-cell-fermentation-technology-global-market-report

Which Key Market Drivers Powering Mammalian Cell Fermentation Technology Market Expansion and Growth?
The surge in demand for biologics is anticipated to drive the mammalian cell fermentation technology market's expansion. Biologics, medical products originating from living beings or their components, are commonly utilized in combating illnesses such as cancer, autoimmune diseases, and infectious disorders. This rise in demand is catalyzed by biotechnology advancements and their efficacy in managing widespread chronic diseases, regulatory endorsements, and increasing investments in R&D. Mammalian cell fermentation technology is proficient at producing sophisticated biologics, fulfilling the growing demand for custom made and targeted medicines. This technology's scalability, versatility, and capacity to manufacture premium quality proteins spur advancements in the biopharmaceutical sector. For example, the National Library of Medicine, a US medical library reported in February 2024, that in 2023 the FDA approved 55 new drugs, comprising 29 new chemical entities (NCEs) and 25 new biological entities (NBEs), recording a 50% surge compared to the 37 approvals in 2022. Consequently, this growing demand for biologics is accelerating the growth of the bacterial cell fermentation technology market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16473&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Mammalian Cell Fermentation Technology Market?
Primary players in the mammalian cell fermentation technology arena are honing their focus on the creation of novel technologies such as mammalian cell culture. This is in an effort to consolidate their dominance within the industry. These cultures are instrumental across multiple fields such as biomanufacturing, research and regenerative medicine, as it expedites the production of therapeutic proteins, vaccines, and functional cells or tissue analogs. A notable contribution was made in June 2024 by Syntegon, a biotech firm rooted in Germany. They launched their groundbreaking Modular Bioprocessing Platform (MBP) at Achema 2024. The MBP, conceived to address significant hurdles in biopharmaceutical manufacture, provides an adaptable, fully amalgamated, and automated solution proficient in a diverse range of applications. It includes microbial and mammalian cell cultures, proteins, peptides, oligonucleotides, plasmid DNA, and recombinant vaccines. The component-based structure of the MBP facilitates shorter delivery times and tempered costs, all while upholding high functionality and quality, in line with the "made in Germany" standard. Its preconstructed cleanroom design situates all ancillary technology outside the cleanroom, which boosts efficiency and eases maintenance.

What Are the Emerging Segments in the Mammalian Cell Fermentation Technology Market?
The mammalian cell fermentation technology market covered in this report is segmented -

1) By Type: Chinese Hamster Cell Fermentation, Human Embryonic Kidney Cell Fermentation, Baby Hamster Kidney Cell Fermentation, Murine Myeloma Cell Fermentation, Other Types
2) By Application: Monoclonal Antibodies, Recombinant Proteins, Vaccines, Hormones, Enzymes, Other Applications
3) By End-Use: Biopharmaceutical Companies, Contract Research Organizations And Contract Development and Manufacturing Organizations, Academic And Research Institutes

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=16473&type=smp

Who Are the Global Leaders in the Mammalian Cell Fermentation Technology Market?
Major companies operating in the mammalian cell fermentation technology market are AbbVie Inc., Thermo Fisher Scientific Inc, AstraZeneca PLC, Roche Holdings Inc., Merck KGaA, AGC Group, Lonza Group Ltd., Boehringer Ingelheim GmbH, Catalent Inc., Sartorius AG, Samsung Biologics Co. Ltd., WuXi Biologics, Biocon Limited, Eppendorf AG, KBI Biopharma Inc., Fujifilm Diosynth Biotechnologies, Avid Bioservices Inc., BiOZEEN, Nordmark Pharma GmbH, Scorpius BioManufacturing Inc

Which are the Top Profitable Regional Markets for the Mammalian Cell Fermentation Technology Industry?
North America was the largest region in the mammalian cell fermentation technology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mammalian cell fermentation technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16473

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.